Re: Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): A randomised phase 3 trial

Samir S. Taneja

    Research output: Contribution to journalComment/debatepeer-review

    Original languageEnglish (US)
    Pages (from-to)412-413
    Number of pages2
    JournalJournal of Urology
    Volume188
    Issue number2
    DOIs
    StatePublished - Aug 2012

    ASJC Scopus subject areas

    • Urology

    Cite this